Literature DB >> 8571901

Preoperative staging of cancer of the pancreas: value of MR angiography versus conventional angiography in detecting portal venous invasion.

E G McFarland1, J A Kaufman, S Saini, E F Halpern, D S Lu, A C Waltman, A L Warshaw.   

Abstract

OBJECTIVE: The purpose of this study was to compare contrast-enhanced MR angiography with conventional catheter angiography for detecting portal venous invasion in the preoperative staging of pancreatic cancer, using the surgical confirmation of vascular involvement as the standard of truth. SUBJECTS AND METHODS: MR and conventional angiography were performed in 20 patients with pancreatic carcinoma, with surgical confirmation in all cases. MR angiography was performed at 1.5 T, with coronal (2.9 mm) and axial (6.0 mm) contrast-enhanced breath-hold two-dimensional time-of-flight imaging. Data from each imaging technique were collected prospectively and analyzed in a blinded fashion by expert vascular radiologists. Vascular involvement in each patient and in each vessel (main portal vein, confluence, splenic vein, and superior mesenteric vein) determined whether the tumor was resectable (normal, abutment) or nonresectable (encased, occluded). Surgical confirmation of the vascular involvement of the portal venous structures was used as the standard of truth in all patients.
RESULTS: Among the 20 patients, 11 tumors were surgically resectable and seven were nonresectable with performance of a palliative bypass. MR angiography and conventional angiography had an overall concordance in 65% of patients (13/20; seven resectable, four nonresectable, two false-negatives) on the basis of the vascular status in each patient of the portal venous structures and in 84% (47/56) of the individual vessels surgically confirmed. MR angiography correctly identified 11 of 11 resectable patients and five of nine nonresectable patients, with four false-negative cases. Conventional angiography correctly identified seven of 11 resectable patients and six of nine nonresectable patients, with three false-negative cases and four false-positive cases.
CONCLUSION: The lack of false-positives by MR angiography suggests that MR imaging may provide a noninvasive screen for nonresectability on the basis of vascular involvement, with no patients with potentially resectable tumors being denied surgery by MR angiography in this cohort. However, the presence of false-negatives using MR angiography indicates the procedure would still not fully eliminate unnecessary laparotomies.

Entities:  

Mesh:

Year:  1996        PMID: 8571901     DOI: 10.2214/ajr.166.1.8571901

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

Review 1.  Magnetic resonance imaging of pancreatic adenocarcinoma.

Authors:  L M Fayad; D G Mitchell
Journal:  Int J Gastrointest Cancer       Date:  2001

Review 2.  Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Domenico Tamburrino; Deniece Riviere; Mohammad Yaghoobi; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-09-15

3.  MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings.

Authors:  Gabriele Masselli; Riccardo Manfredi; Amorino Vecchioli; Gianfranco Gualdi
Journal:  Eur Radiol       Date:  2008-05-08       Impact factor: 5.315

4.  Magnetic resonance angiography in the resectability assessment of suspected pancreatic tumours.

Authors:  O Smedby; V Riesenfeld; B Karlson; G Jacobson; A Löfberg; P G Lindgren; H Ahlström
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

Review 5.  Pancreatic cancer: can we screen? How should we stage?

Authors:  A A Parikh; A M Lowy
Journal:  Curr Gastroenterol Rep       Date:  1999-04

Review 6.  Surgery of resectable nonfunctioning neuroendocrine pancreatic tumors.

Authors:  Henning Dralle; Sabine L Krohn; Wolfram Karges; Bernhard O Boehm; Michael Brauckhoff; Oliver Gimm
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

7.  Assessment of vascular invasion in pancreatic head cancer with multislice spiral CT: value of multiplanar reconstructions.

Authors:  Melanie Brügel; Thomas M Link; Ernst J Rummeny; Peter Lange; Jörg Theisen; Martin Dobritz
Journal:  Eur Radiol       Date:  2004-04-09       Impact factor: 5.315

8.  Preliminary clinical application of contrast-enhanced MR portography.

Authors:  L Yang; X Kong; D Liu; X Xiao; G Feng
Journal:  J Tongji Med Univ       Date:  1999

9.  Objective Assessment of Surgical Restaging after Concurrent Chemoradiation for Locally Advanced Pancreatic Cancer.

Authors:  Woo Hyun Paik; Sang Hyub Lee; Yong-Tae Kim; Jin Myung Park; Byeong Jun Song; Ji Kon Ryu
Journal:  J Korean Med Sci       Date:  2015-06-10       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.